Detalles de la búsqueda
1.
The Xenobiotic Transporter Mdr1 Enforces T Cell Homeostasis in the Presence of Intestinal Bile Acids.
Immunity
; 47(6): 1182-1196.e10, 2017 12 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-29262351
2.
Whole-genome sequencing of African Americans implicates differential genetic architecture in inflammatory bowel disease.
Am J Hum Genet
; 108(3): 431-445, 2021 03 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33600772
3.
Higher Intra-Abdominal Visceral Adipose Tissue Mass Is Associated With Lower Rates of Clinical and Endoscopic Remission in Patients With Inflammatory Bowel Diseases Initiating Biologic Therapy: Results of the Constellation Study.
Gastroenterology
; 165(4): 963-975.e5, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37499955
4.
Early Life and Childhood Environmental Exposures, More Than Genetic Predisposition, Influence Age of Diagnosis in a Diverse Cohort of 2952 Patients With IBD.
Clin Gastroenterol Hepatol
; 2024 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38309494
5.
Gut Microbiome Composition Is Associated With Future Onset of Crohn's Disease in Healthy First-Degree Relatives.
Gastroenterology
; 165(3): 670-681, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37263307
6.
Environmental Factors Associated with Risk of Crohn's Disease Development in the CCC-GEM Project.
Clin Gastroenterol Hepatol
; 2024 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38759825
7.
Efficacy and Safety of Ustekinumab for Ulcerative Colitis Through 4 Years: Final Results of the UNIFI Long-Term Maintenance Study.
Am J Gastroenterol
; 2024 Jan 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38095692
8.
The Xenobiotic Transporter Mdr1 Enforces T Cell Homeostasis in the Presence of Intestinal Bile Acids.
Immunity
; 52(3): 571, 2020 Mar 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-32187521
9.
The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease.
Gut
; 72(9): 1642-1650, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37339849
10.
Pattern Recognition Receptor Signaling and Cytokine Networks in Microbial Defenses and Regulation of Intestinal Barriers: Implications for Inflammatory Bowel Disease.
Gastroenterology
; 162(6): 1602-1616.e6, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35149024
11.
Combination Therapy With Immunomodulators Improves the Pharmacokinetics of Infliximab But Not Vedolizumab or Ustekinumab.
Clin Gastroenterol Hepatol
; 21(11): 2908-2917.e10, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36280102
12.
Altered Gut Microbiome Composition and Function Are Associated With Gut Barrier Dysfunction in Healthy Relatives of Patients With Crohn's Disease.
Gastroenterology
; 163(5): 1364-1376.e10, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35850197
13.
Mediterranean-Like Dietary Pattern Associations With Gut Microbiome Composition and Subclinical Gastrointestinal Inflammation.
Gastroenterology
; 163(3): 685-698, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35643175
14.
Global Hospitalization Trends for Crohn's Disease and Ulcerative Colitis in the 21st Century: A Systematic Review With Temporal Analyses.
Clin Gastroenterol Hepatol
; 21(9): 2211-2221, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35863682
15.
Patients With Inflammatory Bowel Diseases and Higher Visceral Adipose Tissue Burden May Benefit From Higher Infliximab Concentrations to Achieve Remission.
Am J Gastroenterol
; 118(11): 2005-2013, 2023 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37207314
16.
Development of the global inflammatory bowel disease visualization of epidemiology studies in the 21st century (GIVES-21).
BMC Med Res Methodol
; 23(1): 129, 2023 05 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37231405
17.
A child with CARD14-associated papulosquamous eruption (CAPE) successfully treated with ustekinumab.
Pediatr Dermatol
; 40(6): 1104-1106, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37219506
18.
Prevalence of chewing difficulty in older people in long-term care: A systematic review and meta-analysis.
Gerodontology
; 40(1): 10-25, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34994001
19.
Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis.
N Engl J Med
; 381(13): 1201-1214, 2019 09 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-31553833
20.
Patients With Low Drug Levels or Antibodies to a Prior Anti-Tumor Necrosis Factor Are More Likely to Develop Antibodies to a Subsequent Anti-Tumor Necrosis Factor.
Clin Gastroenterol Hepatol
; 20(2): 465-467.e2, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33421628